Cell Culture Media and Reagents Market Analysis North America, APAC, Europe, Rest of World (ROW) - US, Canada, Japan, China, Germany - Size and Forecast 2023-2027

Cell Culture Media and Reagents Market Forecast 2023-2027

The Global Cell Culture Media and Reagent market size is estimated to grow by USD 4.81 billion, at a CAGR of 8.14% between 2022 and 2027. The field of life sciences is rapidly evolving, with significant innovations and breakthroughs in the field. In order to treat and cure disease, the healthcare sector is being gradually shaped by the technology employed in surgeries and biomedical technologies. The requirement for increases to support the growth of cells to carry out the required experiments. Also, the importance of genetic engineering is rising as researchers modify the genetic makeup of organisms to produce various drugs like human growth hormone, insulin, and vaccines to stimulate the production of antibodies and provide immunity against diseases. 

Moreover, manufacturers are incorporating technologies and providing products that sync with the current state of health care. The advances of recombinant DNA technology include combining DNA from different species in a host organism to produce the desired genetic combinations that can contribute to science or medicine. This market research and growth report also includes an in-depth analysis of drivers, trends, and challenges. Our report examines historic data from 2017 to 2021, besides analyzing the current market scenario.

What will be the size of the Market During the Forecast Period?

To learn more about this market growth analysis report, Request Free Sample

The increasing development of monoclonal antibodies and biosimilars is a key driver behind the growing demand for specialized cell culture media and reagents. Collaboration between academic and research institutes, alongside biopharmaceutical companies, is instrumental in advancing cell culture technologies. Moreover, beyond pharmaceuticals, these products are also finding applications in artificial organ development and tissue engineering, underscoring their expanding utility. With the intersection of biotechnology and pharmaceuticals, the Global Cell Culture Media and Reagents Market is positioned for substantial growth, meeting the dynamic requirements of the pharmaceutical and biotechnology sectors.

Market Segmentation

This market growth analysis report extensively covers market segmentation by end-user (Pharmaceutical And Biotechnology Industry, Academic institutions and research laboratories, and others), product (media and reagents), and geography (APAC, Europe, North America, South America, and Middle East and Africa). Market research and growth report also includes an in-depth analysis of drivers, trends, and challenges. In the Pharmaceutical and Biotechnology Industry segment of the Global Cell Culture Media and Reagents Market, the demand for advanced solutions is evident. With the rise of biological drugs and personalized medicine, biotechnology and pharmaceutical companies are increasingly relying on cell culture media and reagents for the production of biopharmaceuticals. To meet stringent regulatory requirements and ensure product safety, there is a growing preference for serum-free and animal component-free media. This shift away from traditional serum, such as fetal bovine serum (FBS), underscores the industry's commitment to ethical and sustainable practices.

End-user Analysis 

Pharmaceutical And Biotechnology Industry

The market share growth by the Pharmaceutical And Biotechnology Industry segment will be significant during the forecast period. The pharmaceutical and biotechnology industry is primarily involved in the discovery and development of drugs to treat prevalent and new diseases. The pharmaceutical and biotechnology sector is increasing the focus on R&D in cell and gene therapy, given the rapid development of drug demand and increased need for drugs.

Get a glance at the market contribution of various segments View a PDF Sample

The Pharmaceutical And Biotechnology Industry segment was valued at USD 2.65 billion in 2017. Pharmaceutical companies are increasing their R&D expenditures by investing in new product growth like cell and gene therapy products. Cellular and gene therapy products are increasingly regulated and approved by government organizations, encouraging the development of such products. The increasing focus of biotechnology companies on drugs using cellular technologies will contribute to the increased growth of the global Market during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 37% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. The prevalence of chronic and infectious diseases across North America has increased significantly. The rising demand for research activities for the development of new drugs has boosted the demand for cell culture media and reagents, which, in turn, is improving the growth of the Market in North America.

Across North America, there has been an increase in the presence of global and local pharmaceuticals and biopharma companies. The increasing demand for various media and reagents, including for research purposes, is fostering the growth of the market in North America, which is expected to grow significantly during the forecast period.

Buy Now Full Report and Discover More

Market Dynamics and Customer Landscape

The market is driven by the growing demand for biosimilar products and advancements in stem cell research, which requires high-quality consumables and equipment to support cell culture techniques and basic biology and biochemistry studies, serving as crucial components in model systems for bioproduction, drug screening, and addressing chronic diseases in the biopharmaceutical market. There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, market growth and trends, and challenges. 

Key Market Drivers

The rise in the prevalence of chronic and infectious diseases is driving growth in the market. Across the world, the incidence of infectious and chronic diseases is increasing significantly. The prevalence of numerous infectious diseases such as influenza, Middle East Respiratory Syndrome (MERS), and severe acute respiratory syndrome (SARS) is increasing worldwide. The instance of chronic diseases, such as cancer, heart disease, and neurological diseases, is also increasing across the world.

However, treating infectious and chronic diseases is a need for the development of new drugs, which led to the R&D of antiviral drugs, vaccines, and cell-based therapies by using cell culture methods. Several media and reagents are needed for the cell culture method. Hence, the rising prevalence of chronic and infectious diseases is promoting the demand for cell culture media and reagents, fueling the growth of the global Market during the forecast period.

Significant Market Trends

The shift to serum-free cell culture media from serum-based media is a primary trend in the market. The purpose of recapitulating human disease environments such as cancer tumours, is because the cell cultures are often used in laboratories. However, the market is gradually witnessing a shift from serum-based supplements to serum-free supplements in cell culture media. Serum-free media increasingly benefit end-users by saving costs by eliminating the risk of infectious agents while supporting the growth of different types of cells.

Moreover, the protein concentrations are low in serum-free media, it is possible to purify target proteins quickly and easily through several steps by knowing their composition, which allows for easy control of interactions between cells and serum-free media. As serum-free media have several advantages over serum media and for ethical reasons, the market for serum-free media is increasingly being accepted.

Major Market Challenges

The lack of skilled personnel is a major challenge in the market. The procedure for cell culture requires expert professionals like pharmacologists and cell culture scientists to resuspend cells from cold storage, prepare sterile media, cryopreserve cells, perform cell counting, and calculate the growth curve. Another factor driving down the number of students who are graduating in this field is a lack of quality training and courses about cell culture in emerging economies.

Moreover, in developed economies, the lack of basic skills among students on cell cultures, like maintenance of aseptic techniques, preparing media with the appropriate characteristics, passaging, freezing and storage, recovering frozen stocks, and counting viable cells, are leading to a shortage of skilled professionals. The lack of adequate knowledge and a limited number of such professionals to carry out cell cultures is hampering the growth of the market.

Buy Now Full Report and Discover More

Customer Landscape

The Market forecasting report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth and forecasting strategies.

Global Market Customer Landscape

Key Market Players 

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The  market research and growth report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Ajinomoto Co. Inc. - The company offers such as basal media, serum-free media, and cell culture supplements.

• ATCC
• Becton Dickinson and Co.
• Bio-Techne Corp.
• CLS Cell Lines Service GmbH
• Corning Inc.
• Danaher Corp.
• HiMedia Laboratories Pvt. Ltd.
• InvivoGen Corp.
• Kohjin Bio Co. Ltd.
• LGC Science Group Holdings Ltd.
• Lonza Group Ltd.
• Merck KGaA
• Miltenyi Biotec B.V. and Co. KG
• Sartorius AG
• Takara Holdings Inc.
• Thermo Fisher Scientific Inc.
• ZenBio Inc.
• PromoCell GmbH
• FUJIFILM Corp.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market is witnessing a surge in demand driven by the rise of personalized medicine and the development of new therapies such as gene therapies. Key factors impacting the market include the adoption of animal component-free media, which addresses concerns regarding pathogen transmission and animal welfare considerations associated with traditional fetal bovine serum (FBS) usage. Monoclonal antibodies and biosimilars are increasingly being produced using serum-free cell culture processes to ensure consistency in performance and meet high-quality standards set by regulatory authorities. Chemically defined media with traceable constituents are preferred for precise evaluations of cellular function, leading to increased growth and productivity. This shift is reducing batch-to-batch variability and enhancing the impact on performance and safety.

The market is also influenced by various factors such as hormones, serum composition, and limited availability of resources. Efforts to address these challenges have led to the development of chemically defined media with reduced batch-to-batch variability, promoting increased growth and productivity in cell culture processes. Despite budget constraints and underdeveloped infrastructure facilities, advanced equipment and consumables are being utilized for applications such as drug discovery & development, tissue engineering & regenerative medicine, and biopharmaceutical production. Biotechnology & pharmaceutical companies, along with academic & research institutes, are key end users driving the demand for cell culture products and biosimilar products. These advancements also support areas like stem cell research, artificial organs, and contract manufacturing within the industry.

The market plays a crucial role in supporting various aspects of biopharmaceutical production and biological drug development. Through advanced cell culture techniques and the utilization of basic biology and biochemistry principles, researchers create model systems for drug screening and bioproduction. This market is integral to the growth of the biopharmaceutical market, providing essential components for the cultivation and maintenance of cells in vitro. With continuous advancements in cell culture media and reagents, scientists can better mimic physiological conditions, leading to more accurate and reliable results in drug development processes. As biopharmaceuticals continue to gain prominence, the demand for high-quality cell culture products is expected to rise significantly.

Segment Overview

The market analysis and report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027. 

• End-user Outlook 
  • Pharmaceutical and biotechnology industry
  • Academic institutions and research laboratories
  • Others

• Product Outlook 
  • Media
  • Reagents

• Geography Outlook 
  • North America
    • The U.S.
    • Canada
  • Europe
    • The U.K.
    • Germany
    • France
    • Rest of Europe
  • Asia
    • China
    • India
  • Rest of The World
    • Argentina
    • Brazil
    • Australia

Market Scope
Report Coverage	Details
Page number	166
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 8.14%
Market growth 2023-2027	USD 4,810.25 million
Market structure	Fragmented
YoY growth 2022-2023(%)	7.9
Regional analysis	North America, APAC, Europe, and the Rest of the World (ROW)
Performing market contribution	North America at 37%
Key countries	US, Canada, Japan, China, and Germany
Competitive landscape	Leading companies, Market Positioning of companies, Competitive Strategies, and Industry Risks
Key companies profiled	Ajinomoto Co. Inc., ATCC, Becton Dickinson and Co., Bio-Techne Corp., CLS Cell Lines Service GmbH, Corning Inc., Danaher Corp., HiMedia Laboratories Pvt. Ltd., InvivoGen Corp., Kohjin Bio Co. Ltd., LGC Science Group Holdings Ltd., Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Sartorius AG, Takara Holdings Inc., Thermo Fisher Scientific Inc., ZenBio Inc., PromoCell GmbH, and FUJIFILM Corp.
Market dynamics	Market trends and analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our market report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

• CAGR of the market during the forecast period
• Detailed information on factors that will drive the growth of the market  between 2023 and 2027
• Precise estimation of the size of the Market size and its contribution to the market in focus on the parent market
• Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria 
• Companies landscape comparing criticality of inputs and factors of differentiation
• Exclusive Matrix on companies' position and classification
• Accurate predictions about upcoming trends and changes in consumer behavior
• Growth of the market industry across North America, APAC, Europe, and the Rest of the World (ROW)
• A thorough analysis of the market’s competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the growth of Market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch